BillionToOne, Inc.
BLLNNASDAQHealthcareDiagnostics & Research
As of Oct 22, 2026 close
- Market cap
- $5.75B
- P/E (TTM)
- 152.60
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $61.96$150.44
- Volume (live)
- -
- Avg. volume (3M)
- 581.14K
BillionToOne (BLLN) Stock Price & Financial Analysis
BillionToOne Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $102.00 - $105.97 |
|---|---|
| 52-Week High | $150.44 |
| 52-Week Low | $61.96 |
| Open | $104.34 |
| Volume (last close) | 377.56K |
| Average Volume (3M) | 581.14K |
| Revenue (TTM) | 397.41M |
|---|---|
| Net Income (TTM) | 37.71M |
| Free Cash Flow (TTM) | 33.13M |
| EPS (TTM) | $0.79 |
| Profit Margin | 9.49% |
| Operating Margin | 10.90% |
| Return on Equity (ROE) | 7.03% |
| Debt to Equity | 0.27 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 5.75B |
|---|---|
| Shares Outstanding | 54.46M |
| P/E Ratio (TTM) | 152.60 |
| Price to Sales (P/S) | 14.48 |
| Price to Book (P/B) | 10.72 |
| EV/EBITDA | 114.67 |
| 50-Day MA | $101.12 |
|---|---|
| 200-Day MA | $95.73 |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
BillionToOne at a Glance
As of the Oct 22, 2026 close, BillionToOne (BLLN) has a market capitalization of $5.75B. The stock trades at 152.6× trailing earnings and 14.5× sales. Over the trailing twelve months it earned $37.71M on revenue of $397.41M (a 9.5% profit margin) and generated $33.13M of free cash flow. Revenue grew 90.1% year over year.
As of its latest reported balance sheet, it holds $548.63M in cash and securities against $143.92M of debt, a net cash position of $404.71M.
BillionToOne does not currently pay a dividend.
At $105.68 (the Oct 22, 2026 close) it sits within its 52-week range of $61.96 to $150.44, above its 200-day moving average of $95.72.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $128.83, 21.9% above the Oct 22, 2026 close.
Frequently Asked Questions About BillionToOne
What is the current stock price for BLLN?
As of the Oct 22, 2026 close, BLLN stock trades at $105.68. The 52-week range is $61.96–$150.44, with a day range of $102.00–$105.97.
What is the P/E ratio for BLLN?
As of the Oct 22, 2026 close, BillionToOne's trailing twelve-month (TTM) P/E ratio is 152.6, meaning investors pay $152.6 for every $1 of annual earnings. BillionToOne operates in the Healthcare sector.
Does BLLN pay dividends?
BillionToOne does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for BLLN?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for BLLN is Buy. The average 12-month price target is $128.83, a 21.9% upside from the Oct 22, 2026 close of $105.68.
What is the market cap of BLLN?
As of the Oct 22, 2026 close, BillionToOne's market capitalization is $5.75B, classifying it as a mid-cap company. BillionToOne operates in the Healthcare sector within the Diagnostics & Research industry.